Donald Trump receiving Covid-19 treatment yet to be peer-reviewed

President’s doctor reveals treatment with experimental antibody cocktail REGN-COV2

Donald Trump is being treated with an experimental antibody drug that has shown promising initial early results but has yet to be peer-reviewed. According to statement from his doctor, the president has received a single eight-gram dose of an antibody cocktail called REGN-COV2 – a combination of two human neutralising antibodies against the virus.

The treatment was developed by Regeneron Pharmaceuticals, which previously developed a similar antibody drug against Ebola. He is also taking zinc, vitamin D, melatonin, aspirin and the heartburn drug famotidine – often sold in the US under the brand name Pepcid. Although the drug has not been shown to work against coronavirus, researchers are studying it as a possible treatment.

Continue reading...

from The Guardian https://ift.tt/3jtFEg0
via
0 Comments